Anti-clotting prospect most important for Lilly, report says

Please subscribe to IBJ to decode this article.

"etT:i p roo"ono ren ep imel roat.rpXdg ld; e t p SsevlyomE,t nnh2oosNol dniiottlrxen-=issB>i=sayme no muro e #&otg rnlIltnit"a o1scpn.n

lststie ePa ltortrsa,edliaepaaybngtrral ms c en etl i adlsirscnec lwa dac m ro hr kh aae slr ea ce,vttrivohuaoy io iik slnl chn t,l inifdusnidslaosaspt.re

r-t oso1caeh/tldiwita c, s g 1" rm,ia he wcygheektopl dmce etnt o"petoHtrD l osdpag_baavai_pmystn=nn.enluwicruai"elwn eni p1ent Isvpo neo hv_r/>e eeisuaoiaedicd>t